| Literature DB >> 8122713 |
J R Causse1, J B Causse, J Uriel, J Berges, G E Shambaugh, P Bretlau.
Abstract
As a medical treatment for otospongiosis-otosclerosis, sodium fluoride influences the underlying bony changes in the labyrinth so as to arrest or prevent the onset of hearing loss. Sodium fluoride is an enzyme inhibitor and reduces osteoclastic bone resorption and, if the dosage is more than 60 mg a day, may rebuild pseudohaversian bone.Entities:
Mesh：
Substances：
Year: 1993 PMID： 8122713 DOI： 10.1097/00129492-199309000-00013
Source DB: PubMed Journal: Am J Otol ISSN： 0192-9763